Informations:
Erreur:
ID
20010
Description
A Study of Albuferon With Ribavirin in Interferon Alfa Naive Subjects With Chronic Hepatitis C Genotype 2 or 3; ODM derived from: https://clinicaltrials.gov/show/NCT00656006
Lien
https://clinicaltrials.gov/show/NCT00656006
Mots-clés
Versions (1)
- 03/02/2017 03/02/2017 -
Téléchargé le
3 février 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Chronic Hepatitis C NCT00656006
Eligibility Chronic Hepatitis C NCT00656006
- StudyEvent: Eligibility
Similar models
Eligibility Chronic Hepatitis C NCT00656006
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Chronic Hepatitis C | Hepatitis C RNA Detectable | Exposure to risk factors Hepatitis C virus
Item
have a clinical diagnosis of chronic hepatitis c on the basis of detectable serum hcv rna during the screening period and at least a 6-month history of exposure to risk factors for hcv.
boolean
C0524910 (UMLS CUI [1])
C0855840 (UMLS CUI [2,1])
C3830527 (UMLS CUI [2,2])
C0332157 (UMLS CUI [3,1])
C0035648 (UMLS CUI [3,2])
C0220847 (UMLS CUI [3,3])
C0855840 (UMLS CUI [2,1])
C3830527 (UMLS CUI [2,2])
C0332157 (UMLS CUI [3,1])
C0035648 (UMLS CUI [3,2])
C0220847 (UMLS CUI [3,3])
Interferon-alpha | Interferon-alpha Combination Product
Item
have never received treatment with an interferon alfa product or an interferon alfa combination product.
boolean
C0002199 (UMLS CUI [1])
C0002199 (UMLS CUI [2,1])
C1880146 (UMLS CUI [2,2])
C0002199 (UMLS CUI [2,1])
C1880146 (UMLS CUI [2,2])
Hepatitis C virus genotype
Item
have hcv genotype 2 or 3.
boolean
C1148363 (UMLS CUI [1])
Compensated liver disease | White Blood Cell Count procedure | Absolute neutrophil count | Platelet Count measurement | Hemoglobin measurement | Gender
Item
have compensated liver disease with the following minimum criteria: white blood cell count (wbc) >3,000/mm3, absolute neutrophil count (anc) > 1,800/mm3, platelets >100,000/mm3, hemoglobin (hb) > 13 g/dl for males and > 12 g/dl for females.
boolean
C3839044 (UMLS CUI [1])
C0023508 (UMLS CUI [2])
C0948762 (UMLS CUI [3])
C0032181 (UMLS CUI [4])
C0518015 (UMLS CUI [5])
C0079399 (UMLS CUI [6])
C0023508 (UMLS CUI [2])
C0948762 (UMLS CUI [3])
C0032181 (UMLS CUI [4])
C0518015 (UMLS CUI [5])
C0079399 (UMLS CUI [6])
Decompensated liver disease Evidence of
Item
evidence of decompensated liver disease.
boolean
C4075847 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
C0332120 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
pregnant or lactating female.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Disease Study Subject Participation Status Inappropriate | Medical condition Study Subject Participation Status Inappropriate
Item
history of any other medical disease or condition that would make the subject (in the opinion of the investigator) unsuitable for the study.
boolean
C0012634 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C1548788 (UMLS CUI [1,3])
C3843040 (UMLS CUI [2,1])
C2348568 (UMLS CUI [2,2])
C1548788 (UMLS CUI [2,3])
C2348568 (UMLS CUI [1,2])
C1548788 (UMLS CUI [1,3])
C3843040 (UMLS CUI [2,1])
C2348568 (UMLS CUI [2,2])
C1548788 (UMLS CUI [2,3])
Substance Dependence
Item
a current drug or alcohol addiction.
boolean
C0038580 (UMLS CUI [1])